AU2003298582A8 - Therapeutic guanidines - Google Patents
Therapeutic guanidinesInfo
- Publication number
- AU2003298582A8 AU2003298582A8 AU2003298582A AU2003298582A AU2003298582A8 AU 2003298582 A8 AU2003298582 A8 AU 2003298582A8 AU 2003298582 A AU2003298582 A AU 2003298582A AU 2003298582 A AU2003298582 A AU 2003298582A AU 2003298582 A8 AU2003298582 A8 AU 2003298582A8
- Authority
- AU
- Australia
- Prior art keywords
- guanidines
- therapeutic
- therapeutic guanidines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41159802P | 2002-09-17 | 2002-09-17 | |
| US60/411,598 | 2002-09-17 | ||
| PCT/US2003/028950 WO2004037166A2 (en) | 2002-09-17 | 2003-09-16 | Therapeutic guanidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003298582A1 AU2003298582A1 (en) | 2004-05-13 |
| AU2003298582A8 true AU2003298582A8 (en) | 2004-05-13 |
Family
ID=32176445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003298582A Abandoned AU2003298582A1 (en) | 2002-09-17 | 2003-09-16 | Therapeutic guanidines |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003298582A1 (en) |
| WO (1) | WO2004037166A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200600492A (en) * | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| EP1917244A2 (en) | 2005-08-24 | 2008-05-07 | Abbott GmbH & Co. KG | Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| EP2474525B1 (en) | 2006-12-26 | 2020-04-15 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
| AR072940A1 (en) * | 2008-08-20 | 2010-09-29 | Schering Corp | PIRIDINE AND PYRIMIDINE DERIVATIVES REPLACED WITH ETHYLLIN AND ITS USE IN THE TREATMENT OF VIRAL INFECTIONS |
| US8470834B2 (en) | 2008-08-20 | 2013-06-25 | Merck Sharp & Dohme Corp. | AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| CA2734489C (en) | 2008-08-20 | 2016-11-08 | Southern Research Institute | Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| EP2326627A1 (en) | 2008-08-20 | 2011-06-01 | Schering Corporation | Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| CA2798488C (en) | 2010-05-11 | 2019-06-04 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| CN104159890B (en) | 2011-09-09 | 2018-04-10 | 蓝瑟斯医学影像公司 | Composition, method and system for synthesizing and using developer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3334455A1 (en) * | 1983-03-04 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | GUANIDIN DERIVATIVES |
-
2003
- 2003-09-16 AU AU2003298582A patent/AU2003298582A1/en not_active Abandoned
- 2003-09-16 WO PCT/US2003/028950 patent/WO2004037166A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004037166A2 (en) | 2004-05-06 |
| AU2003298582A1 (en) | 2004-05-13 |
| WO2004037166A3 (en) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0206876D0 (en) | Therapeutic agents | |
| GB0229931D0 (en) | Therapeutic agents | |
| GB0209991D0 (en) | Therapeutic agents | |
| GB0209997D0 (en) | Therapeutic agents | |
| GB0209995D0 (en) | Therapeutic agents | |
| GB0210127D0 (en) | Therapeutic agents | |
| GB0230087D0 (en) | Therapeutic agents | |
| GB0210124D0 (en) | Therapeutic agents | |
| GB0223349D0 (en) | Therapeutic agents | |
| GB0230088D0 (en) | Therapeutic agents | |
| GB0219660D0 (en) | Therapeutic use | |
| AU2003215150A8 (en) | Therapeutic compounds | |
| GB0218876D0 (en) | Therapeutic agents | |
| AU2003298582A8 (en) | Therapeutic guanidines | |
| GB0217068D0 (en) | Therapeutic agents | |
| GB0226462D0 (en) | Therapeutic agents | |
| GB0225501D0 (en) | Therapeutic agents | |
| GB0208394D0 (en) | Therapeutic agents | |
| GB0208392D0 (en) | Therapeutic compounds | |
| GB0213383D0 (en) | Therapeutic conditions | |
| GB0225399D0 (en) | Therapeutic agents | |
| GB0223118D0 (en) | Therapeutic use | |
| GB0226850D0 (en) | Therapeutic use | |
| GB0224787D0 (en) | Therapeutic use | |
| GB0226865D0 (en) | Therapeutic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |